Skip to main content
SpringerLink
Log in
Book cover

Endocarditis pp 311–331Cite as

Prosthetic Valve Endocarditis and Cardiovascular Device Related Infections

  • Chapter
  • First Online:

  • 971 Accesses

Abstract

Infections are known complications of prosthetic valves (PV) and cardiovascular devices (CD). PV and CD placement is increasing secondary to an extension of the indications for their use as well as an aging population. Thus there is an expanding population at risk for infection. Cardiac devices susceptible to infection include cardiovascular implantable electronic devices, coronary artery stents, pulmonary conduits, ventricular assist devices (VADs), total artificial hearts (TAHs) and intra-aortic balloon pumps. Rates of infections vary between devices with the highest rates occurring for VADs and TAHs.

Given the serious nature of PV and CD-related infections, establishing a prompt diagnosis and identifying the infectious etiology are important. In addition to pathogen-directed antimicrobials, surgical management may be required. Early consultation with a multidisciplinary team including infectious disease specialists, cardiologists, and cardiac surgeons is important to best determine optimal and patient tailored treatment.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Darouiche RO. Device-associated infections: a macroproblem that starts with microadherence. Clin Infect Dis Off Publ Infect Dis Soc Am. 2001;33(9):1567–72. Epub 2001/09/29.

    Article  CAS  Google Scholar 

  2. Arrecubieta C, Asai T, Bayern M, Loughman A, Fitzgerald JR, Shelton CE, et al. The role of Staphylococcus aureus adhesins in the pathogenesis of ventricular assist device-related infections. J Infect Dis. 2006;193(8):1109–19. Epub 2006/03/18.

    Article  CAS  PubMed  Google Scholar 

  3. Heilmann C. Adhesion mechanisms of staphylococci. Adv Exp Med Biol. 2011;715:105–23. Epub 2011/05/11.

    Article  CAS  PubMed  Google Scholar 

  4. Donlan RM. Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis Off Publ Infect Dis Soc Am. 2001;33(8):1387–92. Epub 2001/09/21.

    Article  CAS  Google Scholar 

  5. Chirillo F, Scotton P, Rocco F, Rigoli R, Pedrocco A, Martire P, et al. Management strategies and outcome for prosthetic valve endocarditis. Am J Cardiol. 2013;112(8):1177–81. Epub 2013/07/09.

    Article  PubMed  Google Scholar 

  6. Slipczuk L, Codolosa JN, Davila CD, Romero-Corral A, Yun J, Pressman GS, et al. Infective endocarditis epidemiology over five decades: a systematic review. PLoS One. 2013;8(12):e82665. Epub 2013/12/19.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Wang A, Athan E, Pappas PA, Fowler Jr VG, Olaison L, Pare C, et al. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA. 2007;297(12):1354–61. Epub 2007/03/30.

    Article  CAS  PubMed  Google Scholar 

  8. Murdoch DR, Corey GR, Hoen B, Miro JM, Fowler Jr VG, Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009;169(5):463–73. Epub 2009/03/11.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Pibarot P, Dumesnil JG. Prosthetic heart valves: selection of the optimal prosthesis and long-term management. Circulation. 2009;119(7):1034–48. Epub 2009/02/25.

    Article  PubMed  Google Scholar 

  10. Piper C, Korfer R, Horstkotte D. Prosthetic valve endocarditis. Heart (British Cardiac Society). 2001;85(5):590–3. Epub 2001/04/17.

    Article  CAS  Google Scholar 

  11. Brennan JM, Edwards FH, Zhao Y, O’Brien S, Booth ME, Dokholyan RS, et al. Long-term safety and effectiveness of mechanical versus biologic aortic valve prostheses in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database. Circulation. 2013;127(16):1647–55. Epub 2013/03/30.

    Article  PubMed  Google Scholar 

  12. Farinas MC, Perez-Vazquez A, Farinas-Alvarez C, Garcia-Palomo JD, Bernal JM, Revuelta JM, et al. Risk factors of prosthetic valve endocarditis: a case-control study. Ann Thorac Surg. 2006;81(4):1284–90. Epub 2006/03/28.

    Article  PubMed  Google Scholar 

  13. Leone S, Ravasio V, Durante-Mangoni E, Crapis M, Carosi G, Scotton PG, et al. Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian Study on Endocarditis. Infection. 2012;40(5):527–35. Epub 2012/06/20.

    Article  CAS  PubMed  Google Scholar 

  14. Lopez J, Revilla A, Vilacosta I, Villacorta E, Gonzalez-Juanatey C, Gomez I, et al. Definition, clinical profile, microbiological spectrum, and prognostic factors of early-onset prosthetic valve endocarditis. Eur Heart J. 2007;28(6):760–5. Epub 2007/01/27.

    Article  PubMed  Google Scholar 

  15. Lee JH, Burner KD, Fealey ME, Edwards WD, Tazelaar HD, Orszulak TA, et al. Prosthetic valve endocarditis: clinicopathological correlates in 122 surgical specimens from 116 patients (1985–2004). Cardiovasc Pathol Off J Soc Cardiovasc Pathol. 2011;20(1):26–35. Epub 2009/11/21.

    Article  Google Scholar 

  16. Simsek-Yavuz S, Sensoy A, Kasikcioglu H, Ceken S, Deniz D, Yavuz A, et al. Infective endocarditis in Turkey: aetiology, clinical features, and analysis of risk factors for mortality in 325 cases. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases. 2015;30:106–14.

    Google Scholar 

  17. Boland JM, Chung HH, Robberts FJ, Wilson WR, Steckelberg JM, Baddour LM, et al. Fungal prosthetic valve endocarditis: Mayo Clinic experience with a clinicopathological analysis. Mycoses. 2011;54(4):354–60. Epub 2010/04/22.

    Article  PubMed  Google Scholar 

  18. Houpikian P, Raoult D. Blood culture-negative endocarditis in a reference center: etiologic diagnosis of 348 cases. Medicine. 2005;84(3):162–73. Epub 2005/05/10.

    Article  PubMed  Google Scholar 

  19. Alonso-Valle H, Farinas-Alvarez C, Garcia-Palomo JD, Bernal JM, Martin-Duran R, Gutierrez Diez JF, et al. Clinical course and predictors of death in prosthetic valve endocarditis over a 20-year period. J Thorac Cardiovasc Surg. 2010;139(4):887–93. Epub 2009/08/08.

    Article  PubMed  Google Scholar 

  20. Luk A, Kim ML, Ross HJ, Rao V, David TE, Butany J. Native and prosthetic valve infective endocarditis: clinicopathologic correlation and review of the literature. Malays J Pathol. 2014;36(2):71–81. Epub 2014/09/10.

    PubMed  Google Scholar 

  21. Li JS, Sexton DJ, Mick N, Nettles R, Fowler Jr VG, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis Off Publ Infect Dis Soc Am. 2000;30(4):633–8. Epub 2000/04/19.

    Article  CAS  Google Scholar 

  22. Habib G, Badano L, Tribouilloy C, Vilacosta I, Zamorano JL, Galderisi M, et al. Recommendations for the practice of echocardiography in infective endocarditis. Eur J Echocardiogr J Work Group Echocardiogr Eur Soc Cardiol. 2010;11(2):202–19. Epub 2010/03/13.

    Article  Google Scholar 

  23. Schulz R, Werner GS, Fuchs JB, Andreas S, Prange H, Ruschewski W, et al. Clinical outcome and echocardiographic findings of native and prosthetic valve endocarditis in the 1990s. Eur Heart J. 1996;17(2):281–8. Epub 1996/02/01.

    Article  CAS  PubMed  Google Scholar 

  24. Daniel WG, Mugge A, Martin RP, Lindert O, Hausmann D, Nonnast-Daniel B, et al. Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography. N Engl J Med. 1991;324(12):795–800. Epub 1991/03/21.

    Article  CAS  PubMed  Google Scholar 

  25. Snygg-Martin U, Gustafsson L, Rosengren L, Alsio A, Ackerholm P, Andersson R, et al. Cerebrovascular complications in patients with left-sided infective endocarditis are common: a prospective study using magnetic resonance imaging and neurochemical brain damage markers. Clin Infect Dis Off Publ Infect Dis Soc Am. 2008;47(1):23–30. Epub 2008/05/22.

    Article  Google Scholar 

  26. Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. J Am Dent Assoc. 2007;138(6):739–45, 47–60. Epub 2007/06/05.

    Article  PubMed  Google Scholar 

  27. Lalani T, Chu VH, Park LP, Cecchi E, Corey GR, Durante-Mangoni E, et al. In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis. JAMA Intern Med. 2013;173(16):1495–504. Epub 2013/07/17.

    Article  PubMed  Google Scholar 

  28. Chirouze C, Alla F, Fowler VG, Jr., Sexton DJ, Corey GR, Chu VH, et al. Impact of early valve surgery on outcome of Staphylococcus aureus prosthetic valve infective endocarditis: analysis in the International Collaboration of Endocarditis-Prospective Cohort Study. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2015;60(5):741–9.

    Google Scholar 

  29. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin 3rd JP, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg. 2014;148(1):e1–132. Epub 2014/06/19.

    Article  PubMed  Google Scholar 

  30. Baddour LM, Wilson WR, Bayer AS, Fowler Jr VG, Bolger AF, Levison ME, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005;111(23):e394–434. Epub 2005/06/16.

    Article  PubMed  Google Scholar 

  31. Baddour LM, Wilson WR, Bayer AS, Fowler VG, Jr., Tleyjeh IM, Rybak MJ, et al. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation. 2015;132(15):1435–86.

    Google Scholar 

  32. Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis Off Publ Infect Dis Soc Am. 2011;52(3):e18–55. Epub 2011/01/07.

    Article  Google Scholar 

  33. Dahl A, Rasmussen RV, Bundgaard H, Hassager C, Bruun LE, Lauridsen TK, et al. Enterococcus faecalis infective endocarditis: a pilot study of the relationship between duration of gentamicin treatment and outcome. Circulation. 2013;127(17):1810–7. Epub 2013/04/02.

    Article  CAS  PubMed  Google Scholar 

  34. Arias CA, Murray BE. The rise of the Enterococcus: beyond vancomycin resistance. Nat Rev Microbiol. 2012;10(4):266–78. Epub 2012/03/17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Fernandez-Hidalgo N, Almirante B, Gavalda J, Gurgui M, Pena C, de Alarcon A, et al. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis. Clin Infect Dis Off Publ Infect Dis Soc Am. 2013;56(9):1261–8. Epub 2013/02/09.

    Article  CAS  Google Scholar 

  36. Chirouze C, Athan E, Alla F, Chu VH, Ralph Corey G, Selton-Suty C, et al. Enterococcal endocarditis in the beginning of the 21st century: analysis from the International Collaboration on Endocarditis-Prospective Cohort Study. Clin Microbiol Infect. 2013;19(12):1140–7. Epub 2013/03/23.

    Article  CAS  PubMed  Google Scholar 

  37. Forrest GN, Arnold RS, Gammie JS, Gilliam BL. Single center experience of a vancomycin resistant enterococcal endocarditis cohort. J Infect. 2011;63(6):420–8. Epub 2011/09/17.

    Article  PubMed  Google Scholar 

  38. Pappas PG, Kauffman CA, Andes D, Benjamin Jr DK, Calandra TF, Edwards Jr JE, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis Off Publ Infect Dis Soc Am. 2009;48(5):503–35. Epub 2009/02/05.

    Article  CAS  Google Scholar 

  39. Baddley JW, Benjamin Jr DK, Patel M, Miro J, Athan E, Barsic B, et al. Candida infective endocarditis. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. 2008;27(7):519–29. Epub 2008/02/20.

    Article  CAS  Google Scholar 

  40. Falcone M, Barzaghi N, Carosi G, Grossi P, Minoli L, Ravasio V, et al. Candida infective endocarditis: report of 15 cases from a prospective multicenter study. Medicine. 2009;88(3):160–8. Epub 2009/05/15.

    Article  PubMed  Google Scholar 

  41. Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007;116(15):1736–54. Epub 2007/04/21.

    Article  PubMed  Google Scholar 

  42. Haussig S, Schuler G, Linke A. Worldwide TAVI registries: what have we learned? Clin Res Cardiol Off J German Card Soc. 2014;103(8):603–12. Epub 2014/03/22.

    Article  Google Scholar 

  43. Leshem-Rubinow E, Amit S, Steinvil A, Ben-Assa E, Abramowitz Y, Keren G, et al. Frequency, pattern, and cause of fever following transfemoral transcatheter aortic valve implantation. Am J Cardiol. 2014;113(6):1001–5. Epub 2014/01/28.

    Article  PubMed  Google Scholar 

  44. Loverix L, Juvonen T, Biancari F. Prosthetic endocarditis after transcatheter aortic valve implantation: pooled individual patient outcome. Int J Cardiol. 2014;178c:67–8. Epub 2014/12/03.

    Google Scholar 

  45. Falcone M, Russo A, Mancone M, Carriero G, Mazzesi G, Miraldi F, et al. Early, intermediate and late infectious complications after transcatheter or surgical aortic-valve replacement: a prospective cohort study. Clin Microbiol Infect. 2014;20(8):758–63. Epub 2013/11/26.

    Article  CAS  PubMed  Google Scholar 

  46. Yuan SM, Mishaly D, Shinfeld A, Raanani E. Right ventricular outflow tract reconstruction: valved conduit of choice and clinical outcomes. J Cardiovasc Med (Hagerstown). 2008;9(4):327–37. Epub 2008/03/13.

    Article  Google Scholar 

  47. Van Dijck I, Budts W, Cools B, Eyskens B, Boshoff DE, Heying R, et al. Infective endocarditis of a transcatheter pulmonary valve in comparison with surgical implants. Heart (British Cardiac Society). 2015;101(10):788–93.

    Google Scholar 

  48. McElhinney DB, Benson LN, Eicken A, Kreutzer J, Padera RF, Zahn EM. Infective endocarditis after transcatheter pulmonary valve replacement using the Melody valve: combined results of 3 prospective North American and European studies. Circ Cardiovasc Interv. 2013;6(3):292–300. Epub 2013/06/06.

    Article  PubMed  Google Scholar 

  49. Voigt A, Shalaby A, Saba S. Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003. J Am Coll Cardiol. 2006;48(3):590–1. Epub 2006/08/01.

    Article  PubMed  Google Scholar 

  50. Uslan DZ, Sohail MR, St Sauver JL, Friedman PA, Hayes DL, Stoner SM, et al. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med. 2007;167(7):669–75. Epub 2007/04/11.

    Article  PubMed  Google Scholar 

  51. Johansen JB, Jorgensen OD, Moller M, Arnsbo P, Mortensen PT, Nielsen JC. Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients. Eur Heart J. 2011;32(8):991–8. Epub 2011/01/22.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Greenspon AJ, Patel JD, Lau E, Ochoa JA, Frisch DR, Ho RT, et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll Cardiol. 2011;58(10):1001–6. Epub 2011/08/27.

    Article  PubMed  Google Scholar 

  53. Lekkerkerker JC, van Nieuwkoop C, Trines SA, van der Bom JG, Bernards A, van de Velde ET, et al. Risk factors and time delay associated with cardiac device infections: Leiden device registry. Heart (British Cardiac Society). 2009;95(9):715–20. Epub 2008/11/28.

    Article  CAS  Google Scholar 

  54. Baddour LM, Epstein AE, Erickson CC, Knight BP, Levison ME, Lockhart PB, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation. 2010;121(3):458–77. Epub 2010/01/06.

    Article  PubMed  Google Scholar 

  55. Sandoe JA, Barlow G, Chambers JB, Gammage M, Guleri A, Howard P, et al. Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS), British Cardiovascular Society (BCS), British Heart Valve Society (BHVS) and British Society for Echocardiography (BSE). J Antimicrob Chemother. 2015;70(2):325–59. Epub 2014/10/31.

    Article  CAS  PubMed  Google Scholar 

  56. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol. 2007;49(18):1851–9. Epub 2007/05/08.

    Article  PubMed  Google Scholar 

  57. Tarakji KG, Chan EJ, Cantillon DJ, Doonan AL, Hu T, Schmitt S, et al. Cardiac implantable electronic device infections: presentation, management, and patient outcomes. Heart Rhythm Off J Heart Rhythm Soc. 2010;7(8):1043–7. Epub 2010/05/18.

    Article  Google Scholar 

  58. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, et al. Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection. Mayo Clin Proc. 2008;83(1):46–53. Epub 2008/01/05.

    Article  PubMed  Google Scholar 

  59. Brinker J. Extraction of chronically implanted cardiovascular electronic device leads. Curr Treat Opt Cardiovasc Med. 2014;16(8):325. Epub 2014/06/12.

    Article  Google Scholar 

  60. Tarakji KG, Wazni OM, Harb S, Hsu A, Saliba W, Wilkoff BL. Risk factors for 1-year mortality among patients with cardiac implantable electronic device infection undergoing transvenous lead extraction: the impact of the infection type and the presence of vegetation on survival. Europace. 2014;16(10):1490–5. Epub 2014/08/05.

    Article  PubMed  Google Scholar 

  61. Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson LW, Blume ED, et al. Sixth INTERMACS annual report: a 10,000-patient database. J Heart Lung Transpl Off Publ Int Soc Heart Transpl. 2014;33(6):555–64. Epub 2014/05/27.

    Article  Google Scholar 

  62. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361(23):2241–51. Epub 2009/11/19.

    Article  CAS  PubMed  Google Scholar 

  63. Nienaber JJ, Kusne S, Riaz T, Walker RC, Baddour LM, Wright AJ, et al. Clinical manifestations and management of left ventricular assist device-associated infections. Clin Infect Dis Off Publ Infect Dis Soc Am. 2013;57(10):1438–48. Epub 2013/08/15.

    Article  Google Scholar 

  64. Aslam S, Hernandez M, Thornby J, Zeluff B, Darouiche RO. Risk factors and outcomes of fungal ventricular-assist device infections. Clin Infect Dis Off Publ Infect Dis Soc Am. 2010;50(5):664–71. Epub 2010/02/02.

    Article  Google Scholar 

  65. Gordon RJ, Weinberg AD, Pagani FD, Slaughter MS, Pappas PS, Naka Y, et al. Prospective, multicenter study of ventricular assist device infections. Circulation. 2013;127(6):691–702. Epub 2013/01/15.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Simon D, Fischer S, Grossman A, Downer C, Hota B, Heroux A, et al. Left ventricular assist device-related infection: treatment and outcome. Clin Infect Dis Off Publ Infect Dis Soc Am. 2005;40(8):1108–15. Epub 2005/03/26.

    Article  Google Scholar 

  67. Hannan MM, Husain S, Mattner F, Danziger-Isakov L, Drew RJ, Corey GR, et al. Working formulation for the standardization of definitions of infections in patients using ventricular assist devices. J Heart Lung Transpl Off Publ Int Soc Heart Transpl. 2011;30(4):375–84. Epub 2011/03/23.

    Article  Google Scholar 

  68. Stulak JM, Maltais S, Cowger J, Joyce LD, Daly RC, Park SJ, et al. Prevention of percutaneous driveline infection after left ventricular assist device implantation: prophylactic antibiotics are not necessary. ASAIO J (Am Soc Artif Intern Organs: 1992). 2013;59(6):570–4. Epub 2013/11/01.

    Article  Google Scholar 

  69. Yarboro LT, Bergin JD, Kennedy JL, Ballew CC, Benton EM, Ailawadi G, et al. Technique for minimizing and treating driveline infections. Ann Cardiothorac Surg. 2014;3(6):557–62. Epub 2014/12/17.

    PubMed  PubMed Central  Google Scholar 

  70. Wang JX, Smith JR, Bonde P. Energy transmission and power sources for mechanical circulatory support devices to achieve total implantability. Ann Thorac Surg. 2014;97(4):1467–74. Epub 2014/02/18.

    Article  PubMed  Google Scholar 

  71. Gerosa G, Scuri S, Iop L, Torregrossa G. Present and future perspectives on total artificial hearts. Ann Cardiothorac Surg. 2014;3(6):595–602. Epub 2014/12/17.

    PubMed  PubMed Central  Google Scholar 

  72. Wiesner RH, Rakela J, Ishitani MB, Mulligan DC, Spivey JR, Steers JL, et al. Recent advances in liver transplantation. Mayo Clinic Proc Mayo Clinic. 2003;78(2):197–210. Epub 2003/02/14.

    Article  Google Scholar 

  73. Torregrossa G, Morshuis M, Varghese R, Hosseinian L, Vida V, Tarzia V, et al. Results with SynCardia total artificial heart beyond 1 year. ASAIO J (Am Soc Artif Intern Organs: 1992). 2014;60(6):626–34. Epub 2014/08/28.

    Article  Google Scholar 

  74. Kirsch ME, Nguyen A, Mastroianni C, Pozzi M, Leger P, Nicolescu M, et al. SynCardia temporary total artificial heart as bridge to transplantation: current results at la pitie hospital. Ann Thorac Surg. 2013;95(5):1640–6. Epub 2013/04/09.

    Article  PubMed  Google Scholar 

  75. Bosman WM, Borger van der Burg BL, Schuttevaer HM, Thoma S, Hedeman Joosten PP. Infections of intravascular bare metal stents: a case report and review of literature. Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg. 2014;47(1):87–99. Epub 2013/11/19.

    Article  CAS  Google Scholar 

  76. Kaufmann BA, Kaiser C, Pfisterer ME, Bonetti PO. Coronary stent infection: a rare but severe complication of percutaneous coronary intervention. Swiss Med Wkly. 2005;135(33–34):483–7. Epub 2005/10/07.

    PubMed  Google Scholar 

  77. Wedekind H, Grossekettler U, Matheja P, Kleine-Katthoefer P. PET-CT imaging in the diagnosis of coronary stent infection. J Nucl Cardiol Off Publ Am Soc Nucl Cardiol. 2013;20(6):1184–5. Epub 2013/08/28.

    Article  Google Scholar 

  78. Elieson M, Mixon T, Carpenter J. Coronary stent infections: a case report and literature review. Texas Heart Inst J/Texas Heart Inst St Luke’s Episcopal Hosp Texas Children’s Hosp. 2012;39(6):884–9. Epub 2013/01/11.

    Google Scholar 

  79. Ahn CM, Hong BK, Kim JY, Min PK, Yoon YW, Lee BK, et al. Incidence and natural history of coronary artery aneurysm developing after drug-eluting stent implantation. Am Heart J. 2010;160(5):987–94. Epub 2010/11/26.

    Article  PubMed  Google Scholar 

  80. Gautam SR, Mishra D, Goyal BK. Mechanical intervention and coronary artery aneurysm. J Invasive Cardiol. 2010;22(12):E213–5. Epub 2010/12/04.

    PubMed  Google Scholar 

  81. Cohen M, Urban P, Christenson JT, Joseph DL, Freedman Jr RJ, Miller MF, et al. Intra-aortic balloon counterpulsation in US and non-US centres: results of the Benchmark Registry. Eur Heart J. 2003;24(19):1763–70. Epub 2003/10/03.

    Article  PubMed  Google Scholar 

  82. Crystal E, Borer A, Gilad J, Haick I, Weber G, Alkan M, et al. Incidence and clinical significance of bacteremia and sepsis among cardiac patients treated with intra-aortic balloon counterpulsation pump. Am J Cardiol. 2000;86(11):1281–4, a9. Epub 2000/11/25.

    Article  CAS  PubMed  Google Scholar 

  83. Pawar M, Mehta Y, Ansari A, Nair R, Trehan N. Nosocomial infections and balloon counterpulsation: risk factors and outcome. Asian Cardiovasc Thorac Ann. 2005;13(4):316–20. Epub 2005/11/24.

    Article  PubMed  Google Scholar 

  84. Aksnes J, Abdelnoor M, Berge V, Fjeld NB. Risk factors of septicemia and perioperative myocardial infarction in a cohort of patients supported with intra-aortic balloon pump (IABP) in the course of open heart surgery. Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg. 1993;7(3):153–7. Epub 1993/01/01.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Infectious Diseases, Department of Medicine, University of Alberta, Grey Nun’s Community Hospital, Edmonton, AB, Canada

    Tamara Leah Remington MD, MSc, FRCPC

  2. Division of Infectious Diseases, Department of Medicine, University of Alberta, 1-139 Clinical Sciences Building 11350 – 83 Avenue, Edmonton, AB, T6G 2G3, Canada

    Karen Doucette MD, MSc

Authors
  1. Tamara Leah Remington MD, MSc, FRCPC
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karen Doucette MD, MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karen Doucette MD, MSc .

Editor information

Editors and Affiliations

  1. Heart Institute, University of Ottawa, Ottawa, Ontario, Canada

    Kwan-Leung Chan

  2. Department of Medicine, Health Sciences Centre, WINNIPEG, Manitoba, Canada

    John M. Embil

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing

About this chapter

Cite this chapter

Remington, T.L., Doucette, K. (2016). Prosthetic Valve Endocarditis and Cardiovascular Device Related Infections. In: Chan, KL., Embil, J. (eds) Endocarditis. Springer, Cham. https://doi.org/10.1007/978-3-319-27784-4_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-27784-4_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-27782-0

  • Online ISBN: 978-3-319-27784-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation